my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
03-02-2010: Merck KGaA and Millipore Corporation announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately € 5.3 billion (US$ 7.2 billion). The transaction was approved by the boards of directors of both companies. Millipore and Merck will create a € 2.1 billion (US$ 2.9 billion) worldclass partner for the Life Science sector, achieving significant scale in high-margin specialty products with an attractive growth profile.
“This transaction is very attractive to shareholders, customers and employees of both companies,” said Dr. Karl-Ludwig Kley, Chairman of the Executive Board of Merck. “This is a combination with an excellent strategic fit, which will allow us to cover the entire value chain for our pharma and biopharma customers, offering integrated solutions beyond chemicals.”
Millipore has a strong position in the bioresearch and bioproduction segments, offering a comprehensive range of products, technologies and services for pharma and biotech companies, as well as for academia, to improve laboratory productivity and to develop and optimize manufacturing processes. In 2009 Millipore generated sales of US$ 1.7 billion, with around 6,000 employees in more than 30 countries.
Together, Millipore and Merck will have a significant presence in high-growth segments and an enhanced geographic presence. Combining the research and development capabilities of both companies will create a powerful innovation platform to develop cutting-edge technologies that are tailored even more closely to the needs of customers.
The acquisition is fully in line with Merck’s strategy of focusing on high-margin, specialty products with an attractive growth profile. In addition, the transaction will lead to a more balanced business profile for the Group. Currently the Chemicals business sector generates around 25% of Merck’s total revenues. Following the transaction, the chemicals business will contribute 35% of total Group revenues of € 8.9 billion (pro forma), driven by its strong Liquid Crystals business and the new world-class life science business.
In order to ensure a seamless integration of the two businesses, Merck will apply a “best of both worlds” integration approach across all operating business functions. Merck plans to build on Millipore’s talented workforce and intends to retain its senior management. The company also plans to maintain Millipore’s headquarters in Billerica and combine it with Merck’s U.S. chemicals headquarters. Merck expects that the combined business will generate annual cost synergies of around US$ 100 million (€ 75 million), which Merck expects to realize within three years from the closing of the transaction.
The acquisition will be funded through available cash and a term loan provided by Bank of America Merrill Lynch, BNP Paribas and Commerzbank Aktiengesellschaft. Merck plans to replace part of the facility through the issuance of bonds. Merck is committed to retaining a solid investment-grade rating.
Completion of the acquisition requires the approval of Millipore shareholders, for which Millipore will call a special shareholders meeting, and the satisfaction of other customary conditions, including antitrust clearance. Due to the fact that the two businesses are highly complementary, Merck expects that the transaction will clear regulatory review. Merck anticipates that the transaction will be completed in the second half of 2010, at which time all outstanding shares of Millipore common stock will be exchanged for the right to receive the agreed cash payment.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
Merck Appoints Heads of Corporate Auditing and Corporate Strategy
Merck KGaA announced that Friederike Rotsch has been appointed Head of Corporate Auditing. She reports to Karl-Ludwig Kley, Chairman of the Executive Board of Merck. At the same time, the company announced that Isabel De Paoli will assume the leadership of Corporate Strategy as of January 1 ... more
Merck Opens First Liquid Crystals Application Lab in China
Merck KGaA announced the official opening of its first liquid crystals application laboratory in China. The laboratory is located in Shanghai’s Zhangjiang Hi-Tech Park, and occupies an area of 300 square meters. It is aimed at providing flat panel display manufacturers in the Chinese market ... more
The 2011 Frost & Sullivan Global Product Differentiation Excellence Award in Food Colors has been presented to Merck KGaA for its Candurin® range of pearl effect colors. The Award is in recognition of Merck’s accomplishments in the food colors sector. Frost & Sullivan’s Best Practices Award ... more
Two new reference kits for Spectroquant® Picco and Multy colorimeters
Two new reference kits are now available for the Spectroquant® Picco Cl2/O3/ClO2/CyA/pH and Spectroquant® Multy colorimeters from Merck more
Photometric bromate determination: Faster drinking water analysis
Merck Millipore has developed a new method for measuring bromate in drinking water photometrically more
Innovative Point-of-Use Water Purification Provided by Millipore's New Milli-Q® Integral System
The Milli-Q® Integral water purification system provides you with integrated, reliable lab-scale production of pure and ultrapure water more
Merck Millipore provides all expertise on chromatography in one place
With almost 400 pages, the catalog contains detailed information on a total of around 4,000 Merck Millipore chromatography products more
Merck Millipore is presenting its new Inorganic Reagents Catalog containing more than 1000 individual products for numerous laboratory applications more
The Lab Solutions business unit of Merck Millipore supplies products for research, analytical and clinical laboratories in a wide variety of industries. We are one of the leading suppliers of laboratory chemicals, lab water equipment and consumables. For inorganic chemistry, we offer reagen ... more
Merck Schuchardt OHG, a 100% subsidiary of Merck KGaA, Germany, has, for the last 135 years, been one of the leading German producers and suppliers of organic intermediates, fine chemicals, reagents and solvents for laboratories, medium-sized and bulk production. more
Merck KGaA Completes Millipore Acquisition and Launches New Merck Millipore Division
Merck KGaA announced the successful completion of its acquisition of Millipore Corporation, a leading Life Science company based in Billerica, Massachusetts, USA, for an aggregate purchase price including debt and cash of approximately EUR 5.2 billion (US$ 7.0 billion). Merck agreed to acqu ... more
Merck KGaA to acquire all outstanding Millipore shares for US$ 107 per share in cash
Merck KGaA and Millipore Corporation announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately € 5.3 ... more
Millipore Names New VP of Life Science Business Unit
Millipore Corporation announced the appointment of John Sweeney as Vice President of Millipore’s Life Science SBU. Most recently, Sweeney served as Vice President of Strategy and Marketing services for Millipore’s Bioscience Division. Sweeney joined Millipore in 2003 as Director of Strateg ... more
First Automated Cell Counter that Fits Into the Palm of the Hand
The Scepter™, the industry's first handheld, automated cell counter represents a breakthrough for life science researchers more
Elix® Advantage Water Purification System
To keep pace with the daily needs of your lab, you know it's crucial to have consistent pure water quality as well as the volumes of water you require more
Millipore is a life science leader providing cutting edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the worlds challenging human health issues. From research to development ... more
Millipore is a multinational company with offices and subsidiaries in 47 countries and distributors and dealers in other countries. There are manufacturing sites and R&D sites around the world. With its global infrastructure, Millipore services multinational pharmaceutical and biotechnology ... more
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2011 CHEMIE.DE Information Service GmbH, All rights reserved
